Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Study Type
OBSERVATIONAL
Enrollment
57
Department of Dermatology, Beth Israel Medical Center
New York, New York, United States
Department of Dermatology, St. Luke's-Roosevelt Hospital Center
New York, New York, United States
Quality of life disturbances in people with vitiligo
dermatology life quality indices were you used and correlated with location of disease
Time frame: point prevalence
self-reporting of vitiligo disease symptoms and history
Correlation of the patient survey response with chart documentation was performed.
Time frame: single survey
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.